Han KH - Search Results

1

Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial: A Validation Study of 2021 AASLD Practice Guidance for SBP.

Yim HJ, Kim TH, Suh SJ, Yim SY, Jung YK, Seo YS, Kang SH, Kim MY, Baik SK, Kim HS, Kim YS, Park SY, Kim BI, Park JY, Heo J, Sohn JH, Heo NY, Han KH, Um SH. Yim HJ, et al. Among authors: han kh. Am J Gastroenterol. 2023 Apr 1;118(4):654-663. doi: 10.14309/ajg.0000000000002126. Epub 2023 Jan 3. Am J Gastroenterol. 2023. PMID: 36594820 Clinical Trial.

2

Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial.

Yim HJ, Kim W, Ahn SH, Yang JM, Jang JY, Kweon YO, Cho YK, Kim YJ, Hong GY, Kim DJ, Jung YK, Um SH, Sohn JH, Lee JW, Park SJ, Lee BS, Kim JH, Kim HS, Yoon SK, Kim MY, Lee KS, Lim YS, Lee WS, Han KH. Yim HJ, et al. Among authors: han kh. Am J Gastroenterol. 2020 Aug;115(8):1217-1225. doi: 10.14309/ajg.0000000000000605. Am J Gastroenterol. 2020. PMID: 32355123 Free PMC article. Clinical Trial.

3

Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model.

Kim MY, Baik SK, Park DH, Jang YO, Suk KT, Yea CJ, Lee IY, Kim JW, Kim HS, Kwon SO, Cho MY, Ko SB, Chang SJ, Um SH, Han KH. Kim MY, et al. Among authors: han kh. J Gastroenterol. 2008;43(11):889-96. doi: 10.1007/s00535-008-2239-9. Epub 2008 Nov 18. J Gastroenterol. 2008. PMID: 19012043

4

A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis.

Kim BK, Han KH, Park JY, Ahn SH, Kim JK, Paik YH, Lee KS, Chon CY, Kim DY. Kim BK, et al. Among authors: han kh. Am J Gastroenterol. 2010 Jun;105(6):1382-90. doi: 10.1038/ajg.2009.750. Epub 2010 Jan 19. Am J Gastroenterol. 2010. PMID: 20087336

5

Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study.

Heo J, Seo YS, Yim HJ, Hahn T, Park SH, Ahn SH, Park JY, Park JY, Kim MY, Park SK, Cho M, Um SH, Han KH, Kim HS, Baik SK, Kim BI, Cho SH. Heo J, et al. Among authors: han kh. Gut Liver. 2009 Sep;3(3):197-204. doi: 10.5009/gnl.2009.3.3.197. Epub 2009 Sep 30. Gut Liver. 2009. PMID: 20431746 Free PMC article.

6

Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model.

Kim BK, Kim DY, Han KH, Park JY, Kim JK, Paik YH, Lee KS, Chon CY, Ahn SH. Kim BK, et al. Among authors: han kh. Am J Gastroenterol. 2011 Sep;106(9):1654-62, 1730. doi: 10.1038/ajg.2011.160. Epub 2011 Jun 21. Am J Gastroenterol. 2011. PMID: 21691339

7

A prospective nationwide study of drug-induced liver injury in Korea.

Suk KT, Kim DJ, Kim CH, Park SH, Yoon JH, Kim YS, Baik GH, Kim JB, Kweon YO, Kim BI, Kim SH, Kim IH, Kim JH, Nam SW, Paik YH, Suh JI, Sohn JH, Ahn BM, Um SH, Lee HJ, Cho M, Jang MK, Choi SK, Hwang SG, Sung HT, Choi JY, Han KH. Suk KT, et al. Among authors: han kh. Am J Gastroenterol. 2012 Sep;107(9):1380-7. doi: 10.1038/ajg.2012.138. Epub 2012 Jun 26. Am J Gastroenterol. 2012. PMID: 22733303

8

A 96-week randomized trial of switching to entecavir in chronic hepatitis B patients with a partial virological response to lamivudine.

Heo J, Park JY, Lee HJ, Tak WY, Um SH, Kim DY, Yoon KT, Park SY, Seo YS, Han KH, Cho M, Ahn SH. Heo J, et al. Among authors: han kh. Antivir Ther. 2012;17(8):1563-70. doi: 10.3851/IMP2277. Epub 2012 Aug 8. Antivir Ther. 2012. PMID: 22872647 Clinical Trial.

9

Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage.

Seo YS, Park SY, Kim MY, Kim JH, Park JY, Yim HJ, Jang BK, Kim HS, Hahn T, Kim BI, Heo J, An H, Tak WY, Baik SK, Han KH, Hwang JS, Park SH, Cho M, Um SH. Seo YS, et al. Among authors: han kh. Hepatology. 2014 Sep;60(3):954-63. doi: 10.1002/hep.27006. Epub 2014 Jul 25. Hepatology. 2014. PMID: 24415445 Clinical Trial.

10

A 96-week randomized trial of switching to entecavir in patients who achieved virological suppression on lamivudine therapy.

Ahn SH, Heo J, Park JY, Woo HY, Lee HJ, Tak WY, Um SH, Yoon KT, Park SY, Kim CW, Kim HH, Han KH, Cho M. Ahn SH, et al. Among authors: han kh. J Gastroenterol Hepatol. 2016 Apr;31(4):865-71. doi: 10.1111/jgh.13231. J Gastroenterol Hepatol. 2016. PMID: 26572068 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,587 results

Search Page